KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Change in Cash (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Change in Cash for 17 consecutive years, with -$15.0 million as the latest value for Q4 2025.

  • Quarterly Change in Cash fell 103.33% to -$15.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $124.0 million through Dec 2025, down 48.12% year-over-year, with the annual reading at $124.0 million for FY2025, 48.12% down from the prior year.
  • Change in Cash hit -$15.0 million in Q4 2025 for Bausch Health Companies, up from -$403.0 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $586.0 million in Q2 2025 to a low of -$1.4 billion in Q3 2022.
  • Historically, Change in Cash has averaged -$24.5 million across 5 years, with a median of $21.5 million in 2021.
  • Biggest five-year swings in Change in Cash: crashed 9771.43% in 2022 and later surged 543.94% in 2025.
  • Year by year, Change in Cash stood at $215.0 million in 2021, then crashed by 56.28% to $94.0 million in 2022, then skyrocketed by 93.62% to $182.0 million in 2023, then skyrocketed by 147.8% to $451.0 million in 2024, then tumbled by 103.33% to -$15.0 million in 2025.
  • Business Quant data shows Change in Cash for BHC at -$15.0 million in Q4 2025, -$403.0 million in Q3 2025, and $586.0 million in Q2 2025.